Amed Co., Ltd. (TPEX:7575)

Market Cap	940.50M
Revenue	n/a
Net Income	n/a
Shares Out	30.00M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	1.50 (5.23%)
Ex-Dividend Date	Jun 16, 2025

Volume	30,306
Average Volume	49,358
Open	31.80
Previous Close	31.35
Day's Range	29.50 - 32.00
52-Week Range	27.10 - 63.30
Beta	-0.26
RSI	54.10
Earnings Date	n/a

About Amed Co., Ltd.

Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-acting pain reliever injections under the Naldebain brand name. In addition, it offers pressure injectable implantable port kits under the POLYSITE brand; a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2008
• Employees: 165
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7575